Publications
CER Interview with Cynthia Bens
| Type: | Podcast |
| Date: | August 14, 2012 |
| Related Topics: | Access to Breakthroughs  , Aging Research, Drug Development, Drug Safety, Federal Funding, Health, Medical Innovation, Other Diseases of Aging, Policy, Quality of Care, Research, Vision Loss |

Cynthia Bens is the Director of Public Policy at the not-for-profit Alliance for Aging Research in Washington, D.C. In this capacity, Ms. Bens is responsible for guiding the organization's federal policy work, representing the Alliance in multiple national coalitions, and directing the Accelerate Cure/Treatments for Alzheimer's Disease (ACT-AD) Coalition. For the past eleven years Ms. Bens has worked to inform federal policymakers and educate the public on a variety of issues. For more than half of that time her efforts have centered on the formulation of policies to expedite the development of interventions to treat and prevent many debilitating age-related disease; to remove access barriers to needed treatments and therapies; and to improve the coordination and quality of care seniors receive.
Prior to joining the Alliance in 2006, Ms. Bens was a senior manager of government affairs with the Loeffler Group. As part of its federal government affairs practice, she represented diverse client interests before the U.S. Congress and the administration. Her core areas of focus included appropriations, budget, health care, education, telecommunications, and international trade. Through various other positions on Capitol Hill and in the private sector, she has acquired extensive experience researching and analyzing federal legislation and regulations. Ms. Bens holds a Bachelor’s of Arts degree from New York University with concentrations in Political Science and Women’s Studies.
"However, if {CER} results are poorly communicated, the availability of more information could lead to confusion for patients on what choices are the right ones for them and also confusion for providers on how they should treat their patients."
This podcast series provides expert reactions to the CATT trial data in terms of what it will mean for wAMD patients and professionals, and its potential impact on future trials, policies and innovation.
To listen to interviews on this topic with other experts, click here.
To listen to interviews on this topic with other experts, click here.
Living Longer and Loving It!
Sign up for the Alliance's quarterly newsletter and get timely information on advancements in science, treatment, and health policy that help you "Live Longer and Love It."
